Alisdair Hearn
Development Scientist Sterling Pharma Solutions
Seminars
Monday 23rd February 2026
Residual Toxin Removal: Scale & Phase Appropriate Approaches & Challenges
1:30 pm
- Using three model ADCs with variability in toxin-linker properties to explore residual toxin removal methods and their applicability across a set of key toxin classes
- Assessing challenges in residual toxin removal change from discovery to manufacturing
- Evaluating approaches to improving ADC quality with residual toxin removal
